COMBATTING URGENT VIRAL DISEASE THREATS Dr David Foster, CEO & Managing Director Mr Jason Carroll, Non-Executive Chairman ASX: ILA November 2026 DISCLAIMER Important Information This disclaimer applies to this presentation and the information contained in it (Presentation). By reading this...
Investor webinar presentation
Filed with ASX · · 21 pages · English
Release
Island Pharmaceuticals Ltd on 6ix
In the deck
Earlier from Island Pharmaceuticals
- Investor webinar
- NHP Surgeries Commence Ahead of Galidesivir Marburg Study
- Quarterly Appendix 4C and Activities Report
- Letter to Shareholders, Notice of AGM & Proxy Form
- USAMRIID Marburg study advances towards dosing
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals